Tag: Capsule excipients

Challenges in Encapsulating APIs with a High Tendency for Degradation Addressing Challenges in Encapsulating APIs with a High Tendency for Degradation Context Active Pharmaceutical Ingredients (APIs) that are prone to…

High Variability in Dissolution Due to Poor Powder Blend Homogeneity Addressing High Variability in Dissolution Due to Poor Powder Blend Homogeneity Context Powder blend homogeneity is a critical factor in…

Incompatibility of Certain Solvents with High-Molecular-Weight APIs Addressing the Incompatibility of Certain Solvents with High-Molecular-Weight APIs Context Formulating high-molecular-weight (HMW) active pharmaceutical ingredients (APIs), such as biologics, peptides, or certain…

Difficulty in Reducing Capsule Brittleness under Low Humidity Conditions Addressing the Difficulty in Reducing Capsule Brittleness under Low Humidity Conditions Context Capsules, particularly soft gelatin capsules, are often sensitive to…

Limited Excipient Options for Maintaining Capsule Transparency Addressing Limited Excipient Options for Maintaining Capsule Transparency Context Capsules are often preferred for pharmaceutical formulations due to their ease of swallowing, accurate…

Issues with Stability of Probiotic Formulations in Capsule Form Addressing Issues with Stability of Probiotic Formulations in Capsule Form Context Probiotic formulations are essential for supporting gut health and immune…

Complexity in Combining Controlled-Release and Immediate-Release Profiles in Capsules Addressing the Complexity in Combining Controlled-Release and Immediate-Release Profiles in Capsules Context Combining controlled-release (CR) and immediate-release (IR) profiles within the…

Difficulty in Developing Fast-Dissolving Capsules Addressing the Difficulty in Developing Fast-Dissolving Capsules Context Fast-dissolving capsules are critical for ensuring rapid onset of action for certain APIs, especially those used for…

Variability in Drug Release Due to Minor Formulation Changes Addressing Variability in Drug Release Due to Minor Formulation Changes Context Minor changes in pharmaceutical formulations, including adjustments to excipient composition,…

Issues with Formulating Drugs with Strong Oxidative Potential Addressing Issues with Formulating Drugs with Strong Oxidative Potential Context Drugs with strong oxidative potential pose significant challenges during the formulation process,…

Limited Options for Shell Materials That Are Free from Animal Origin Addressing the Limited Options for Shell Materials That Are Free from Animal Origin Context The use of soft gelatin…

Problems with Encapsulating Drugs with Variable Particle Size Distribution Addressing Problems with Encapsulating Drugs with Variable Particle Size Distribution Context The encapsulation of drugs with variable particle size distribution (PSD)…